NCT00978549 Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer Status COMPLETED Phase PHASE3
NCT00963092 Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer Status UNKNOWN Phase N/A
NCT00961077 Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer Status UNKNOWN Phase PHASE2
NCT00960349 Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients Status COMPLETED Phase PHASE1
NCT00952497 A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT00952003 Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients Status COMPLETED Phase PHASE2
NCT00941655 Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial Status COMPLETED Phase PHASE3
NCT00938470 Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT00917384 Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma Status COMPLETED Phase PHASE3
NCT00911820 Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT00903396 Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer Status TERMINATED Phase PHASE2
NCT00899626 Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients Status RECRUITING Phase N/A
NCT00896467 Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy Status TERMINATED Phase N/A
NCT00887822 A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT00865982 Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer Status UNKNOWN Phase PHASE2
NCT00858338 Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer Status COMPLETED Phase PHASE2
NCT00857246 Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer Status COMPLETED Phase PHASE2